Viewing Study NCT02354534


Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2026-03-14 @ 6:41 PM
Study NCT ID: NCT02354534
Status: COMPLETED
Last Update Posted: 2021-04-28
First Post: 2015-01-13
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Intravaginal Artesunate for the Treatment of HPV+ High Grade Cervical Intraepithelial Neoplasia (CIN2/3)
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cervical Intraepithelial Neoplasia Grade 2/3 View
None High-risk HPV (Any Strain) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cervical dysplasia View
None HPV View
None Treatment View
None preinvasive View
None cervix View
None vaginal suppository View
None Cornelia Trimble View
None abnormal pap View
None CIN View